{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:36:09Z","timestamp":1787315769113,"version":"build-2736575974"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"34","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rheumatic heart disease (RHD) is the result of episodes of acute rheumatic fever with valvular (and other cardiac) damage caused by an abnormal immune response to group A streptococcal infections, usually during childhood and adolescence. As a result of improved living conditions and the introduction of penicillin, RHD was almost eradicated in the developed world by the 1980s. However, being a disease of poverty, its burden remains disproportionately high in the developing world, despite being a fundamentally preventable disease. Rheumatic heart disease generates relatively little attention from the medical and science communities, in contrast to other common infectious problems (such as malaria, HIV, tuberculosis), despite the major cardiovascular morbidity\/mortality burden imposed by RHD. This relative neglect and paucity of funding have probably contributed to limited fundamental medical advances in this field for over 50\u2009years. Given the importance of prevention before the onset of major valvular damage, the main challenges for RHD prevention are improving social circumstances, early diagnosis, and effective delivery of antibiotic prophylaxis. Early identification through ultrasound of silent, subclinical rheumatic valve lesions could provide an opportunity for early intervention. Simple echocardiographic diagnostic criteria and appropriately trained personnel can be valuable aids in large-scale public health efforts. In addition, a better understanding of the immunogenic determinants of the disease may provide potential routes to vaccine development and other novel therapies.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehab407","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T15:06:27Z","timestamp":1623596787000},"page":"3338-3348","source":"Crossref","is-referenced-by-count":67,"title":["Persisting burden and challenges of rheumatic heart disease"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7227-3428","authenticated-orcid":false,"given":"Eloi","family":"Marijon","sequence":"first","affiliation":[{"name":"University of Paris, PARCC, INSERM, Global Health Unit , Paris F-75015, France"},{"name":"Cardiology Department, European Georges Pompidou Hospital , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mocumbi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universidade Eduardo Mondlane , Maputo, Mozambique"},{"name":"Instituto Nacional de Sa\u00fade , Marracuene, Mozambique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4897-240X","authenticated-orcid":false,"given":"Kumar","family":"Narayanan","sequence":"additional","affiliation":[{"name":"University of Paris, PARCC, INSERM, Global Health Unit , Paris F-75015, France"},{"name":"Medicover Hospitals , Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Jouven","sequence":"additional","affiliation":[{"name":"University of Paris, PARCC, INSERM, Global Health Unit , Paris F-75015, France"},{"name":"Cardiology Department, European Georges Pompidou Hospital , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7640-0439","authenticated-orcid":false,"given":"David S","family":"Celermajer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of Sydney , Sydney, Australia"},{"name":"Royal Prince Alfred Hospital Department of Cardiology, , Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"2022102610212585300_ehab407-B1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"2022102610212585300_ehab407-B2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/eurheartj\/ehu507","article-title":"The stark reality of rheumatic heart disease","volume":"36","author":"Carapetis","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102610212585300_ehab407-B3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","article-title":"A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease","volume":"24","author":"Lung","year":"2003","journal-title":"Eur Heart J"},{"key":"2022102610212585300_ehab407-B4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrcardio.2010.202","article-title":"Epidemiology of valvular heart disease in the adult","volume":"8","author":"Iung","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2022102610212585300_ehab407-B5","first-page":"780","volume":"377"},{"key":"2022102610212585300_ehab407-B6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"Lancet"},{"key":"2022102610212585300_ehab407-B7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(18)30999-1","article-title":"Acute rheumatic fever","volume":"392","author":"Karthikeyan","year":"2018","journal-title":"Lancet"},{"key":"2022102610212585300_ehab407-B8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamacardio.2020.7063","article-title":"Screening for rheumatic heart disease-quo vadis?","volume":"6","author":"Narayanan","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2022102610212585300_ehab407-B9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/eurheartj\/14.1.122","article-title":"Rheumatic heart disease in the developing world: prevalence, prevention, and control","volume":"14","author":"Eisenberg","year":"1993","journal-title":"Eur Heart J"},{"key":"2022102610212585300_ehab407-B10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(05)66874-2","article-title":"Acute rheumatic fever","volume":"366","author":"Carapetis","year":"2005","journal-title":"Lancet"},{"key":"2022102610212585300_ehab407-B11","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.268.15.2069","article-title":"Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association","volume":"268","year":"1992","journal-title":"JAMA"},{"key":"2022102610212585300_ehab407-B12","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurheartj\/ehp530","article-title":"Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study","volume":"31","author":"Sliwa","year":"2010","journal-title":"Eur Heart J"},{"key":"2022102610212585300_ehab407-B14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.eurheartj.a061194","article-title":"Critical assessment of two-dimensional echocardiographic estimation of the mitral valve area in rheumatic mitral valve disease: calcific deposits in the valve as a major determinant of the accuracy of the method","volume":"2","author":"Marino","year":"1981","journal-title":"Eur Heart J"},{"key":"2022102610212585300_ehab407-B15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(16)00547-X","article-title":"Valvular aspects of rheumatic heart disease","volume":"387","author":"Remenyi","year":"2016","journal-title":"Lancet"},{"key":"2022102610212585300_ehab407-B16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"2022102610212585300_ehab407-B17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.gheart.2013.08.008","article-title":"Estimates of the global burden of rheumatic heart disease","volume":"8","author":"Zuhlke","year":"2013","journal-title":"Glob Heart"},{"key":"2022102610212585300_ehab407-B18","first-page":"215","article-title":"Prevalence of heart disease in school children in rural Kenya using colour-flow echocardiography","volume":"73","author":"Anabwani","year":"1996","journal-title":"East Afr Med J"},{"key":"2022102610212585300_ehab407-B19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamacardio.2020.7050","article-title":"Effectiveness of systematic echocardiographic screening for rheumatic heart disease in Nepalese schoolchildren: a cluster randomized clinical trial","volume":"6","author":"Karki","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2022102610212585300_ehab407-B20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ncpcardio1185","article-title":"Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren","volume":"5","author":"Carapetis","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022102610212585300_ehab407-B21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/clc.4960201105","article-title":"Doppler echocardiography distinguishes between physiologic and pathologic \u2018silent\u2019 mitral regurgitation in patients with rheumatic fever","volume":"20","author":"Minich","year":"1997","journal-title":"Clin Cardiol"},{"key":"2022102610212585300_ehab407-B22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijcard.2015.07.005","article-title":"Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease?","volume":"198","author":"Remond","year":"2015","journal-title":"Int J Cardiol"},{"key":"2022102610212585300_ehab407-B23","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIRCULATIONAHA.113.007855","article-title":"Cardiology patient page. Prevention of acute rheumatic fever and rheumatic heart disease","volume":"130","author":"Mirabel","year":"2014","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/rheumatology\/keq290","article-title":"The resurgence of rheumatic fever in a developed country area: the role of echocardiography","volume":"50","author":"Pastore","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2022102610212585300_ehab407-B25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCULATIONAHA.108.836510","article-title":"Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa?","volume":"120","author":"Karthikeyan","year":"2009","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B26","first-page":"135","article-title":"Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002","volume":"19","author":"Nordet","year":"2008","journal-title":"Cardiovasc J Afr"},{"key":"2022102610212585300_ehab407-B27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198702193160801","article-title":"Resurgence of acute rheumatic fever in the intermountain area of the United States","volume":"316","author":"Veasy","year":"1987","journal-title":"N Engl J Med"},{"key":"2022102610212585300_ehab407-B28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2261-5-11","article-title":"Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis","volume":"5","author":"Robertson","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"2022102610212585300_ehab407-B29","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1097\/INF.0b013e3181a8e12a","article-title":"Meta-analysis of trials of streptococcal throat treatment programs to prevent rheumatic fever","volume":"28","author":"Lennon","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2022102610212585300_ehab407-B30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/INF.0b013e3181a282be","article-title":"School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand","volume":"28","author":"Lennon","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2022102610212585300_ehab407-B31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2018.06.063","article-title":"Rheumatic heart disease worldwide: JACC scientific expert panel","volume":"72","author":"Watkins","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102610212585300_ehab407-B32","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1136\/heartjnl-2015-308237","article-title":"Newly diagnosed rheumatic heart disease among indigenous populations in the Pacific","volume":"101","author":"Mirabel","year":"2015","journal-title":"Heart"},{"key":"2022102610212585300_ehab407-B33","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.109.191959","article-title":"Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B34","year":"2004"},{"key":"2022102610212585300_ehab407-B35","first-page":"565","article-title":"Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease","volume":"45","author":"Saxena","year":"2008","journal-title":"Indian Pediatr"},{"key":"2022102610212585300_ehab407-B36"},{"key":"2022102610212585300_ehab407-B37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5694\/mja2.50851","article-title":"The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease","volume":"214","author":"Ralph","year":"2021","journal-title":"Med J Aust"},{"key":"2022102610212585300_ehab407-B38","first-page":"31","article-title":"A study of rheumatic heart disease and rheumatic fever in a defined population in Sri Lanka","volume":"40","author":"Mendis","year":"1997","journal-title":"Ceylon J Med Sci"},{"key":"2022102610212585300_ehab407-B39","year":"1994"},{"key":"2022102610212585300_ehab407-B40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrcardio.2012.7","article-title":"World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease\u2014evidence-based guideline","volume":"9","author":"Remenyi","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"2022102610212585300_ehab407-B41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2471\/BLT.07.046680","article-title":"Echocardiographic screening for rheumatic heart disease","volume":"86","author":"Marijon","year":"2008","journal-title":"Bull World Health Organ"},{"key":"2022102610212585300_ehab407-B42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa065085","article-title":"Prevalence of rheumatic heart disease detected by echocardiographic screening","volume":"357","author":"Marijon","year":"2007","journal-title":"N Engl J Med"},{"key":"2022102610212585300_ehab407-B43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.109.849190","article-title":"Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease","volume":"120","author":"Marijon","year":"2009","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B44","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00246-014-0925-3","article-title":"Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection","volume":"35","author":"Beaton","year":"2014","journal-title":"Pediatr Cardiol"},{"key":"2022102610212585300_ehab407-B45","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1161\/CIRCULATIONAHA.112.092312","article-title":"Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren","volume":"125","author":"eaton","year":"2012","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B46","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/CIRCULATIONAHA.117.029936","article-title":"Latent rheumatic heart disease: identifying the children at highest risk of unfavorable outcome","volume":"136","author":"Beaton","year":"2017","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/chd.12756","article-title":"Two-year evolution of latent rheumatic heart disease in Malawi","volume":"14","author":"Sanyahumbi","year":"2019","journal-title":"Congenit Heart Dis"},{"key":"2022102610212585300_ehab407-B48","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1136\/heartjnl-2011-300792","article-title":"Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study","volume":"97","author":"Saxena","year":"2011","journal-title":"Heart"},{"key":"2022102610212585300_ehab407-B49","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1016\/S2214-109X(14)70310-9","article-title":"Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents","volume":"2","author":"Rothenb\u00fchler","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2022102610212585300_ehab407-B50","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/heartjnl-2015-307444","article-title":"Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia","volume":"101","author":"Engel","year":"2015","journal-title":"Heart"},{"key":"2022102610212585300_ehab407-B51","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/s41598-019-53540-4","article-title":"Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies","volume":"9","author":"Noubiap","year":"2019","journal-title":"Sci Rep"},{"key":"2022102610212585300_ehab407-B52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jpc.12087","article-title":"High prevalence of rheumatic heart disease in schoolchildren detected by echocardiography screening in New Caledonia","volume":"49","author":"Baroux","year":"2013","journal-title":"J Paediatr Child Health"},{"key":"2022102610212585300_ehab407-B53","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ehjci\/jes077","article-title":"Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach","volume":"13","author":"Mirabel","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102610212585300_ehab407-B54","doi-asserted-by":"crossref","first-page":"e002324","DOI":"10.1161\/CIRCIMAGING.114.002324","article-title":"Screening for rheumatic heart disease: evaluation of a focused cardiac ultrasound approach","volume":"8","author":"Mirabel","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022102610212585300_ehab407-B55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.acvd.2015.01.002","article-title":"Pocket-sized focused cardiac ultrasound: strengths and limitations","volume":"108","author":"Mirabel","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"2022102610212585300_ehab407-B56","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijcard.2012.10.090","article-title":"Echocardiographic screening for rheumatic heart disease: age matters","volume":"168","author":"Kane","year":"2013","journal-title":"Int J Cardiol"},{"key":"2022102610212585300_ehab407-B57","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.ijcard.2012.11.083","article-title":"Challenges of using ultrasounds for subclinical rheumatic heart disease screening","volume":"167","author":"Grimaldi","year":"2013","journal-title":"Int J Cardiol"},{"key":"2022102610212585300_ehab407-B58","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1540-8175.2011.01487.x","article-title":"Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations","volume":"28","author":"Bhaya","year":"2011","journal-title":"Echocardiography"},{"key":"2022102610212585300_ehab407-B59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ahj.2019.06.001","article-title":"Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): study protocol for a randomized controlled trial","volume":"215","author":"Beaton","year":"2019","journal-title":"Am Heart J"},{"key":"2022102610212585300_ehab407-B60","first-page":"e201704","article-title":"Towards developing a vaccine for rheumatic heart disease","volume":"2017","author":"Gandhi","year":"2017","journal-title":"Glob Cardiol Sci Pract"},{"key":"2022102610212585300_ehab407-B61","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1099\/jmm.0.2008\/001156-0","article-title":"Superantigen genes in group A streptococcal isolates and their relationship with emm types","volume":"57","author":"Commons","year":"2008","journal-title":"J Med Microbiol"},{"key":"2022102610212585300_ehab407-B62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1172\/JCI7132","article-title":"Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin","volume":"106","author":"Galvin","year":"2000","journal-title":"J Clin Invest"},{"key":"2022102610212585300_ehab407-B63","first-page":"833","article-title":"Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes","volume":"12","author":"Dale","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2022102610212585300_ehab407-B64","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"2022102610212585300_ehab407-B65","doi-asserted-by":"crossref","first-page":"e00429","DOI":"10.1128\/mSphere.00429-20","article-title":"Systematic review and meta-analysis of the prevalence of group A Streptococcal emm clusters in Africa to inform vaccine development","volume":"5","author":"Salie","year":"2020","journal-title":"mSphere"},{"key":"2022102610212585300_ehab407-B66","doi-asserted-by":"crossref","first-page":"e0007511","DOI":"10.1371\/journal.pntd.0007511","article-title":"Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease","volume":"13","author":"Giffard","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2022102610212585300_ehab407-B67","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1038\/s41598-019-46244-2","article-title":"Group A Streptococcus adsorbed vaccine: repeated intramuscular dose toxicity test in minipigs","volume":"9","author":"Postol","year":"2019","journal-title":"Sci Rep"},{"key":"2022102610212585300_ehab407-B68","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1017\/S1047951114002212","article-title":"The challenges of managing rheumatic disease of the mitral valve in Jamaica","volume":"24","author":"Little","year":"2014","journal-title":"Cardiol Young"},{"key":"2022102610212585300_ehab407-B69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurheartj\/18.suppl_D.130","article-title":"Stress echocardiography beyond coronary artery disease","volume":"18","author":"Schwammenthal","year":"1997","journal-title":"Eur Heart J"},{"key":"2022102610212585300_ehab407-B70","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102610212585300_ehab407-B71","first-page":"e35","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2018.09.043","article-title":"Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: a meta-analysis","volume":"273","author":"Cao","year":"2018","journal-title":"Int J Cardiol"},{"key":"2022102610212585300_ehab407-B73","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/hrt.60.4.299","article-title":"Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation","volume":"60","author":"Wilkins","year":"1988","journal-title":"Br Heart J"},{"key":"2022102610212585300_ehab407-B74","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.113.001252","article-title":"The echo score revisited: impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty","volume":"129","author":"Nunes","year":"2014","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B75","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1161\/CIR.0000000000000921","article-title":"Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association","volume":"142","author":"Kumar","year":"2020","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.acvd.2008.09.012","article-title":"What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure?","volume":"101","author":"Marijon","year":"2008","journal-title":"Arch Cardiovasc Dis"},{"key":"2022102610212585300_ehab407-B77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtcvs.2009.04.022","article-title":"Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery","volume":"139","author":"Song","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022102610212585300_ehab407-B78","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/CIRCULATIONAHA.111.055905","article-title":"Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients","volume":"125","author":"Bouleti","year":"2012","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B79","doi-asserted-by":"crossref","first-page":"ytz155","DOI":"10.1093\/ehjcr\/ytz155","article-title":"Successful MitraClip for severe rheumatic mitral regurgitation: a case report","volume":"3","author":"Wong","year":"2019","journal-title":"Eur Heart J Case Rep"},{"key":"2022102610212585300_ehab407-B80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijcard.2019.01.015","article-title":"TAVI for rheumatic aortic stenosis, the next frontier?","volume":"280","author":"Ntsekhe","year":"2019","journal-title":"Int J Cardiol"},{"key":"2022102610212585300_ehab407-B81","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/heartjnl-2017-312674","article-title":"Repair for rheumatic mitral valve disease. The controversy goes on!","volume":"104","author":"Antunes","year":"2018","journal-title":"Heart"},{"key":"2022102610212585300_ehab407-B82","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ejcts\/ezt035","article-title":"Leaflet extension in rheumatic mitral valve reconstruction","volume":"44","author":"Dillon","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022102610212585300_ehab407-B83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/icvts\/ivy234","article-title":"Is it worth repairing rheumatic mitral valve disease in children? Long-term outcomes of an aggressive approach to rheumatic mitral valve repair compared to replacement in young patients","volume":"28","author":"Krishna Moorthy","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2022102610212585300_ehab407-B84","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.hlc.2020.01.014","article-title":"Should moderate functional tricuspid regurgitation be repaired during surgery for rheumatic mitral valve disease?","volume":"29","author":"Fawzy","year":"2020","journal-title":"Heart Lung Circ"},{"key":"2022102610212585300_ehab407-B85","doi-asserted-by":"crossref","first-page":"e7193","DOI":"10.1097\/MD.0000000000007193","article-title":"Minimally invasive mitral valve replacement is a safe and effective surgery for patients with rheumatic valve disease: a retrospective study","volume":"96","author":"Zhai","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2022102610212585300_ehab407-B86","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1532\/hsf.2529","article-title":"Minimally invasive mitral valve surgery for rheumatic valve disease","volume":"22","author":"Vo","year":"2019","journal-title":"Heart Surg Forum"},{"key":"2022102610212585300_ehab407-B87","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/0218492320932743","article-title":"Contemporary trends in mitral valve surgery in East China: a 10-year experience","volume":"28","author":"Ma","year":"2020","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"2022102610212585300_ehab407-B88","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(15)60235-5","article-title":"Access to cardiac surgery in sub-Saharan Africa","volume":"385","author":"Mirabel","year":"2015","journal-title":"Lancet"},{"key":"2022102610212585300_ehab407-B89","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5830\/CVJA-2018-044","article-title":"The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease","volume":"29","author":"Mocumbi","year":"2018","journal-title":"Cardiovasc J Afr"},{"key":"2022102610212585300_ehab407-B90","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/CIRCULATIONAHA.117.032561","article-title":"Pregnancy outcomes in women with rheumatic mitral valve disease: results from the Registry of Pregnancy and Cardiac Disease","volume":"137","author":"Van Hagen","year":"2018","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.crd.0000214187.79296.3c","article-title":"P-wave dispersion and percutaneous mitral valvuloplasty","volume":"15","author":"Marijon","year":"2007","journal-title":"Cardiol Rev"},{"key":"2022102610212585300_ehab407-B92","doi-asserted-by":"crossref","first-page":"e004304","DOI":"10.1161\/CIRCOUTCOMES.117.004304","article-title":"Rheumatic heart disease: is continuum of care achievable in Africa?","volume":"10","author":"Mocumbi","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2022102610212585300_ehab407-B93","doi-asserted-by":"crossref","first-page":"e004037","DOI":"10.1161\/CIRCOUTCOMES.117.004037","article-title":"Rheumatic heart disease treatment cascade in Uganda","volume":"10","author":"Longenecker","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2022102610212585300_ehab407-B94","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gheart.2018.08.002","article-title":"Global unmet needs in cardiac surgery","volume":"13","author":"Zilla","year":"2018","journal-title":"Glob Heart"},{"key":"2022102610212585300_ehab407-B95","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.4314\/ahs.v15i4.17","article-title":"Proportion of patients in the Uganda rheumatic heart disease registry with advanced disease requiring urgent surgical interventions","volume":"15","author":"Zhang","year":"2015","journal-title":"Afr Health Sci"},{"key":"2022102610212585300_ehab407-B96","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCULATIONAHA.116.024769","article-title":"Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)","volume":"134","author":"Zuhlke","year":"2016","journal-title":"Circulation"},{"key":"2022102610212585300_ehab407-B97","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0034-1383723","article-title":"Cardiac surgery capacity in sub-Saharan Africa: quo vadis?","volume":"62","author":"Yankah","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"2022102610212585300_ehab407-B98","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5830\/CVJA-2014-034","article-title":"Cardiac surgery for patients with heart failure due to structural heart disease in Uganda: access to surgery and outcomes","volume":"25","author":"Grimaldi","year":"2014","journal-title":"Cardiovasc J Afr"},{"key":"2022102610212585300_ehab407-B99","doi-asserted-by":"crossref","first-page":"102740","DOI":"10.1016\/j.autrev.2020.102740","article-title":"Rheumatic heart disease: a review of the current status of global research activity","volume":"20","author":"Dooley","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2022102610212585300_ehab407-B100","doi-asserted-by":"crossref","first-page":"14946","DOI":"10.1038\/ncomms14946","article-title":"Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania","volume":"8","author":"Parks","year":"2017","journal-title":"Nat Commun"},{"key":"2022102610212585300_ehab407-B101","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/eurheartj\/ehab036","article-title":"Artificial intelligence in global health","volume":"42","author":"Krittanawong","year":"2021","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/34\/3338\/46642435\/ehab407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/34\/3338\/46642435\/ehab407.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T06:35:18Z","timestamp":1666766118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/34\/3338\/6321664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":101,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2021,7,15]]},"published-print":{"date-parts":[[2021,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab407","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,7]]},"published":{"date-parts":[[2021,7,15]]}}}